Parmjit “Paul” Parmar admitted to orchestrating a scheme to inflate a company’s value and defraud investors in a high-stakes effort to take the firm private.
NEWARK, N.J. — The former chief executive officer of a healthcare services company admitted guilt in federal court this month to participating in a complex investment fraud scheme that misled investors and financial institutions out of over $200 million, U.S. Attorney Alina Habba announced.…